Cleared Traditional

K172507 - SOZO

K172507 is an FDA 510(k) clearance for SOZO, manufactured by ImpediMed Limited. The device is a Class 2 Cardiovascular device with product code DSB cleared through the Traditional 510(k) pathway after a 126-day FDA review.

K172507 · ImpediMed Limited · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2017
Decision
126d
Days
Class 2
Risk

K172507 is an FDA 510(k) clearance for the SOZO. Classified as Plethysmograph, Impedance (product code DSB), Class II - Special Controls.

Submitted by ImpediMed Limited (Pinkenba, AU). The FDA issued a Cleared decision on December 22, 2017 after a review of 126 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2770 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all ImpediMed Limited devices

FDA 510(k) Submission Details - K172507

510(k) Number K172507 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 18, 2017
Decision Date December 22, 2017
Days to Decision 126 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
1d slower than avg
Panel avg: 125d · This submission: 126d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DSB Device Classification - Class 2, Special Controls

Product Code DSB Plethysmograph, Impedance
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2770
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DSB Plethysmograph, Impedance

All 18
Devices cleared under the same product code (DSB) and FDA review panel - the closest regulatory comparables to K172507.
Cardiac Monitor 1500
K191697 · Zynex Medical, Inc. · Feb 2020
ReDS System
K180479 · Sensible Medical Innovations , Ltd. · Feb 2019
Cardiovascular Analzyer
K172431 · Physiowave, Inc. · Mar 2018
ECOM ENDOTRACHEAL CARDIAC OUTPUT MONITOR SYSTEM
K131765 · Conmed Corporation · Dec 2013
BIO Z CARDIO PROFILE HEMODYNAMIC MONITOR
K110645 · Sonosite,Inc. · Jun 2011
C3 AND LIFEGARD ICG IMPEDANCE CARDIOGRAPHY MONITORS
K041434 · Analogic Corp. · Aug 2004